Testing effectiveness (Phase 2)Study completedNCT04906421
What this trial is testing
Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)
Who this might be right for
Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease
Sagimet Biosciences Inc. 168